NEWS | AEMPS Update on Fast-Track Procedure for Clinical Trials in Spain

May 24, 2024
|

The Spanish Agency for Medicines and Health Products (AEMPS) has launched a fast-track accelerated evaluation procedure specifically for: Phase I Clinical trials involving ATMPs

Advantages of the procedure:

  • Evaluation in maximum 26 days since validation
  • Possible authorization in 31 days, if no RFIs are raised

Requirements:

  • To study serious debilitating diseases or life-threatening conditions in patients who have no therapeutic alternatives
  • To be conducted exclusively in Spain
  • To select an Ethics Committee (CEIm) adhering to the fast-track procedure

This procedure represents an excellent opportunity to boost medical research of innovative medicines in Spain.

For more information about this procedure, do not hesitate to contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | DIA Europe

DIA Europe 2025 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2025 will be the prime opportunity to discuss how collaboration and innovation can support sustainability in healthcare and each stakeholder’s role in making it happen.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting